Queensland Cystic Fibrosis Research Program

Queensland Cystic Fibrosis Research Program is Queensland’s first cystic fibrosis research program established to help improve outcomes for patients living with the life-threatening genetic disorder. 

The program was announced in October 2019 and is supported by $15 million of funding from The University of Queensland, US-based Cystic Fibrosis FoundationChildren’s Hospital FoundationDepartment of Health Medical Research Future Fund and an anonymous donor.

Two new research projects will be the focus of the program, the Early Life Origins of CF lung disease (the ELO study), and the Mycobacterium abscessus (MABS) pulmonary disease program.

The research will be carried out in partnership with Children’s Health Queensland Hospital and Health Service, the Metro North Hospital and Health Service and The Prince Charles Hospital.